Article
Immunology
Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, Po-Liang Lu, Shu-Hsing Cheng, Wen-Chien Ko, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Wen-Sen Lee, Zhi-Yuan Shi, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Chao-Nan Lin, Yu-Hui Chen, Wang-Huei Sheng, Chun-Ming Lee, Hung-Jen Tang, Chun-Yu Lin, Yen-Hsu Chen, Po-Ren Hsueh
Summary: The study suggests that empirical treatment with ceftriaxone monotherapy for pneumococcal meningitis should be carefully monitored due to its high non-susceptibility rate. However, the high susceptibility rates of most isolates to other antibiotics such as penicillin, carbapenems, respiratory quinolones, vancomycin, and linezolid indicate their potential in treating pneumococcal diseases in Taiwan.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
(2022)
Article
Infectious Diseases
Zhiyong Lyu, Jing Li, Jinghui Zhen, Wei Shi, Qingying Meng, Wei Zhou, Jingyun An, Kaihu Yao, Fang Dong
Summary: This study revealed that Streptococcus pneumoniae is one of the most commonly detected bacteria in pediatric clinical samples, especially in children under 5 years old. Penicillin remains the first-choice drug for treating non-meningitis pneumococcal infections, while erythromycin should not be involved in the treatment.
INFECTION AND DRUG RESISTANCE
(2023)
Article
Immunology
Mariana M. Lanata, Huanyu Wang, Kathy Everhart, Melisa Moore-Clingenpeel, Octavio Ramilo, Amy Leber
Summary: The study found that rates of MRMp infections in children in central Ohio are low, but patients with MRMp had longer hospitalizations, were more likely to have received previous macrolides, and were more likely to have switched to alternative antimicrobial drugs compared to patients with MSMp. MRMp-infected patients also had approximately 5-fold greater odds of pediatric intensive care unit admission.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Microbiology
Bekele Sharew, Feleke Moges, Gizachew Yismaw, Wondwossen Abebe, Surafal Fentaw, Didrik Vestrheim, Belay Tessema
Summary: This study aimed to assess the antimicrobial resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae isolates from patients suspected of pneumococcal infections in Ethiopia. Most isolates were susceptible to ceftriaxone and cefotaxime, but resistance to commonly used antibiotics including penicillin was observed, indicating the need for periodic monitoring to select appropriate empirical treatments for better management of pneumococcal infection.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
(2021)
Article
Infectious Diseases
Nourelhouda Ben Ayed, Sonia Ktari, Sonda Mezghani, Basma Mnif, Faouzia Mahjoubi, Adnene Hammami
Summary: In Tunisia, a study was conducted to determine the relationship between serotypes and antimicrobial nonsusceptibility of Streptococcus pneumoniae isolates recovered from clinical samples prior to the introduction of PCV10 in the national immunization program. The study found high rates of penicillin nonsusceptibility and multidrug resistance among the isolates, with associations noted between specific serotypes and these resistance patterns. The results highlight the importance of monitoring the impact of the newly introduced PCV10 on pneumococcal antimicrobial resistance in Tunisia.
MICROBIAL DRUG RESISTANCE
(2022)
Article
Infectious Diseases
Hanfang Jiang, Qing Meng, Xiaorong Liu, Hongyu Chen, Chunqing Zhu, Yunsheng Chen
Summary: This study characterizes the molecular epidemiology of invasive Streptococcus pneumoniae in Shenzhen. The coverage of PCV13 was 88.9%, and nonvaccine serotypes included 15b, 16F, and 20. The multidrug resistance rate was 91.3%, with nonmeningitis isolates showing no resistance to penicillin and 98.8% of all isolates being resistant to erythromycin. Continued surveillance is needed to monitor antibiotic-resistant nonvaccine serotypes and highly virulent serotypes.
INFECTION AND DRUG RESISTANCE
(2021)
Article
Multidisciplinary Sciences
Soumeya Hema-Ouangraoua, Juliette Tranchot-Diallo, Issaka Zongo, Nongodo Firmin Kabore, Frederic Nikiema, Rakiswende Serge Yerbanga, Halidou Tinto, Daniel Chandramohan, Georges-Anicet Ouedraogo, Brian Greenwood, Jean-Bosco Ouedraogo
Summary: The study demonstrates that azithromycin can reduce the carriage rate of Staphylococcus aureus in children, but the azithromycin resistance of S. aureus was not significantly affected. In addition, there was a high level of penicillin resistance, while Methicillin-Resistant Staphylococcus Aureus (MRSA) was detected in only a few cases. Monitoring antibiotic resistance in S. aureus and other bacteria is crucial in Burkina Faso due to unregulated antibiotic consumption putting children and others at risk.
Article
Immunology
Eileen M. Dunne, Yinglei Hua, Rasheed Salaudeen, Ilias Hossain, Malick Ndiaye, Belinda D. Ortika, E. Kim Mulholland, Jason Hinds, Sam Manna, Grant A. Mackenzie, Catherine Satzke
Summary: We investigated the pathogenesis of pneumococcal pneumonia using clinical samples. Results demonstrated that pneumococci in the lung originated from the nasopharynx and suggested that changes in pneumococcal gene expression in the lung are a feature of pneumococcal pneumonia.
JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Immunology
Alyssa R. Golden, Heather J. Adam, Melanie Baxter, Irene Martin, Walter Demczuk, Michael R. Mulvey, James A. Karlowsky, George G. Zhanel
Summary: This study characterized invasive and respiratory Streptococcus pneumoniae isolates collected from Canadian hospitals pre and post-PCV13 implementation, particularly focusing on serotypes 22F and 33F using whole genome sequencing. The results showed emergence of new drug-resistant serotypes and different performance of vaccine serotypes at different time points.
Article
Microbiology
Charlie Higgs, Lamali Sadeesh Kumar, Kerrie Stevens, Janet Strachan, Tony Korman, Kristy Horan, Diane Daniel, Madeline Russell, Christopher A. Mcdevitt, Norelle L. Sherry, Timothy P. Stinear, Benjamin P. Howden, Claire L. Gorrie
Summary: Streptococcus pneumoniae is an important human pathogen, and non-invasive isolates may serve as a source of invasive isolates and reservoirs of antimicrobial resistance (AMR) determinants. By comparing the genomes and antibiotic resistance profiles of invasive and non-invasive isolates, we found that non-invasive isolates exhibited higher levels of resistance to multiple antibiotics and certain sub-populations with high levels of AMR were overrepresented in the non-invasive population.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2023)
Article
Microbiology
Alessandra Carattoli, Gabriele Arcari, Giulia Bibbolino, Federica Sacco, Dario Tomolillo, Federica Maria Di Lella, Maria Trancassini, Luigi Faino, Mario Venditti, Guido Antonelli, Giammarco Raponi
Summary: A study conducted in a university hospital in Rome, Italy identified multiple CZA-resistant KPC-3 protein variants, including novel variants that had not been reported before. These variants showed different sensitivities and activities to antibiotics, possibly due to mutations caused by amino acid substitutions, insertions, and deletions.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2021)
Article
Microbiology
Helene Gingras, Flora Peillard-Fiorente, Chantal Godin, Kevin Patron, Philippe Leprohon, Marc Ouellette
Summary: Two strains of Streptococcus pneumoniae with or without erm(B) were selected for solithromycin resistance in vitro. Mutants with decreased solithromycin susceptibility were obtained and characterized by next-generation sequencing. Various mutations in ribosomal proteins, 23S rRNA, phosphate transporter subunits, helicase CshB, and erm(B)L leader peptide were identified.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2023)
Review
Microbiology
Damaris Berbel, Aida Gonzalez-Diaz, Guillem Lopez de Egea, Jordi Camara, Carmen Ardanuy
Summary: This study focuses on the macrolide resistance rates, genetic associated determinants, and antibiotic consumption data in Spain, Europe, and globally. Macrolide resistance determinants are differently distributed worldwide and associated with different clonal lineages and mobile genetic elements. Resistance rates vary depending on clonal dynamics and antibiotic consumption.
Article
Immunology
Jonathan Zintgraff, Paula Gagetti, Daniela Napoli, Nahuel Sanchez Eluchans, Lucia Irazu, Maria Moscoloni, Mabel Regueira, Claudia S. Lara, Alejandra Corso
Summary: This study analyzed the epidemiology of invasive pneumococcal diseases and found that the introduction of PCV13 vaccine led to a significant increase in non-PCV13 serotypes and a decrease in PCV13 serotypes. Some serotypes remained common despite being included in the vaccine. Additionally, there was an increase in erythromycin resistance, particularly in serotype 14 and serogroup 24.
Article
Infectious Diseases
Balaji Veeraraghavan, Rosemol Varghese, Karnika Saigal, S. Balasubramanian, P. Sulochana Putli Bai, Binesh Y. Lal, Ayyanraj Neeravi, Pavithra Baskar, Kavipriya Anandhan, C. P. Girish Kumar, Yuvraj Jayaraman, Vijaya Lakshmi Nag, Sujata Baveja, J. Bhavana, Shrikrishna A. Joshi, Ranganathan Iyer
Summary: Indian pneumococcal isolates exhibit poor susceptibilities to macrolides, in line with the global trend. However, Nafithromycin demonstrates potent activity against these isolates regardless of the resistance mechanisms. This study supports the continued clinical development of Nafithromycin for pneumococcal infections in India.
JAC-ANTIMICROBIAL RESISTANCE
(2021)
Article
Infectious Diseases
Sarah E. Costello, Lalitagauri M. Deshpande, Andrew P. Davis, Rodrigo E. Mendes, Mariana Castanheira
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
(2019)
Article
Microbiology
S. J. Ryan Arends, Paul R. Rhomberg, Nicole Cotroneo, Aileen Rubio, Robert K. Flamm, Rodrigo E. Mendes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2019)
Article
Immunology
Daniel J. Diekema, Michael A. Pfaller, Dee Shortridge, Marcus Zervos, Ronald N. Jones
OPEN FORUM INFECTIOUS DISEASES
(2019)
Article
Immunology
Dee Shortridge, Ana C. Gales, Jennifer M. Streit, Michael D. Huband, Athanasios Tsakris, Ronald N. Jones
OPEN FORUM INFECTIOUS DISEASES
(2019)
Article
Oncology
Michael A. Pfaller, Helio S. Suter, Dee Shortridge, Mariana Castanheira, Robert K. Flamm, Rodrigo E. Mendes
JOURNAL OF CHEMOTHERAPY
(2019)
Article
Infectious Diseases
Leonard R. Duncan, Caitlin J. Smith, Robert K. Flamm, Rodrigo E. Mendes
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
(2020)
Article
Microbiology
Fred C. Tenover, Isabella A. Tickler, Victoria M. Le, Scott Dewell, Rodrigo E. Mendes, Richard Goering, Megan Farrington, Shirley Maneth, Margaret Noddin
JOURNAL OF CLINICAL MICROBIOLOGY
(2019)
Article
Microbiology
Mariana Castanheira, Timothy B. Doyle, Valerie Kantro, Rodrigo E. Mendes, Dee Shortridge
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2020)
Editorial Material
Microbiology
Jason M. Pogue, Ronald N. Jones, John S. Bradley, David R. Andes, Sujata M. Bhavnani, George L. Drusano, Michael N. Dudley, Robert K. Flamm, Keith A. Rodvold, Paul G. Ambrose
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2020)
Article
Microbiology
E. Wenzler, K. M. Meyer, S. C. Bleasdale, M. Sikka, R. E. Mendes, K. L. Bunnell, M. Finnemeyer, S. L. Rosenkranz, L. H. Danziger, K. A. Rodvold
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2020)
Article
Microbiology
M. Biagi, X. Tan, T. Wu, M. Jurkovic, A. Vialichka, K. Meyer, R. E. Mendes, E. Wenzler
JOURNAL OF CLINICAL MICROBIOLOGY
(2020)
Letter
Infectious Diseases
H. S. Sader, R. N. Jones
CLINICAL MICROBIOLOGY AND INFECTION
(2020)
Article
Microbiology
Mariana Castanheira, Helio S. Sader, Rodrigo E. Mendes, Ronald N. Jones
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2020)
Article
Infectious Diseases
Hien M. Nguyen, Ronald N. Jones
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
(2020)
Article
Immunology
Paul G. Ambrose, Sujata M. Bhavnani, David R. Andes, John S. Bradley, Robert K. Flamm, Jason M. Pogue, Ronald N. Jones
OPEN FORUM INFECTIOUS DISEASES
(2020)